Diagnostic Imaging Pathways Logo

  • Pathways
  • Normal Anatomy
  • Medical Images
  • Radiation Module
  • Radiation Quiz
  • Menu
  • Search

Salivary Gland Swelling

Population Covered By The Guidance

This pathway provides guidance on the imaging investigation of an adult patient with a salivary gland swelling

Lead Researcher: Dr Ben Milne

Experts & Contributors: Dr Daren Gibson, Prof Peter Friedland, Dr Mark Fiorentino

Date reviewed: August 2025

Date Published: December 2025, Minor revision: August 2026, Clin Prof Richard Mendelson

Image 1a and 1b (Sialogram): There is considerable dilatation of the intraglandular radicles particularly low in the gland. The parotid duct has a narrowing just distal to the confluence with the accessory duct (arrow), this latter not being dilated. The narrow segment is fairly short and is only a relative narrowing, not an obstruction. There is no calculus identified.

Salivary Gland Swelling with Ductal Narrowing

Image 1a and 1b (Sialogram): There is considerable dilatation of the intraglandular radicles particularly low in the gland. The parotid duct has a narrowing just distal to the confluence with the accessory duct (arrow), this latter not being dilated. The narrow segment is fairly short and is only a relative narrowing, not an obstruction. There is no calculus identified.

Salivary Gland Swelling with Ductal Narrowing

Image 2a and 2b: Resection of the parotid gland showing a (a) pleomorphic adenoma with the typical well circumscribed, pale appearance and focal areas of chondroid (cartilagenous) differentiation (arrow) and a (b) Warthin's tumour (Papillary cystadenoma lymphomatosum) with a tan cut surface demonstrating several cystic spaces.

Salivary Gland Tumour

Image 2a and 2b: Resection of the parotid gland showing a (a) pleomorphic adenoma with the typical well circumscribed, pale appearance and focal areas of chondroid (cartilagenous) differentiation (arrow) and a (b) Warthin's tumour (Papillary cystadenoma lymphomatosum) with a tan cut surface demonstrating several cystic spaces.

Salivary Gland Tumour

  • There are many causes of salivary gland swelling, including:
    • Neoplasms (benign or malignant)
    • Sialolithiasis or ductal stenosis
    • Infection (e.g. mumps, bacterial)
    • Autoimmune diseases (e.g. Sjögren’s syndrome, IgG4-related dacroadenitis and sialadenitis)
    • Sialadenosis from systemic diseases (e.g. diabetes mellitus, Cushing’s syndrome, metabolic disturbances)
    • Lymphadenopathy or apparent swelling due to enlargement of adjacent structures
  • Clinical history and examination are important to guide choice of imaging and for diagnosis, especially considerations of acuity of presentation, and presence of systemic features.
  • Ultrasound is usually the first line imaging modality in undifferentiated salivary gland swelling and is recommended after 3 weeks of persistent salivary gland swelling.
  • Certain “red flag” features include facial nerve palsy, suspected involvement of the deep lobe of the parotid, minor salivary gland, or a past medical history of scalp or facial skin cancers, should warrant urgent specialist referral and MRI for further investigation. 
  • Of all salivary gland tumours, 70% arise from the parotid gland. Of all parotid gland tumours, 75% of these are benign.
  • When neoplasia is suspected, after ultrasound, MRI is the recommended complementary imaging modality.
  • Imaging guided fine needle aspiration cytology of mass lesions is generally undertaken to guide further management, however may impair exact characterisation via MRI if performed in the previous 3 weeks.
  • Surgery is the recommended treatment for the majority of both benign and malignant salivary gland neoplasms. Differentiating between benign and malignant neoplasms is important for surgical planning.
  • Conventional or MR sialography can be used to identify or further characterise sialolithiasis or duct stricture, with conventional sialography being a potentially diagnostic and therapeutic procedure. 
  • CT investigation for salivary gland swelling is now considered a poor choice and can be falsely reassuring. 
  • There is evolving literature surrounding the exploration of utilising positron emission technology (PET) for both diagnostic and therapeutic options in salivary gland tumours, however this is not currently recommended in routine clinical practice and data are sparse.
  • The need for staging CT chest or PET-CT should be guided by grade of tumour and risk of locoregional/distant disease, which will be dictated under specialist guidance.

  1. Alvi S, Chudek D, Limaiem F. Parotid Cancer. Statpearls. 2023 (Review Article). https://www.ncbi.nlm.nih.gov/books/NBK538340/#article-26690.s7
  2. Afzelius P, Nielsen MY, Ewertsen C, Bloch KP. Imaging of the major salivary glands. Clin Physiol Funct Imaging. 2016;36(1):1-10 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/25319072
  3. Mehanna H, McQueen A, Robinson M, Paleri V. Salivary gland swellings. BMJ. 2012;345(oct23 1):e6794-e (Review article). https://www.ncbi.nlm.nih.gov/pubmed/23418969
  4. Sobrino-Guijarro B, Cascarini L, Lingam RK. Advances in imaging of obstructed salivary glands can improve diagnostic outcomes. Oral Maxillofac Surg. 2013;17(1):11-9 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/22562281
  5. Burke CJ, Thomas RH, Howlett D. Imaging the major salivary glands. Br J Oral Maxillofac Surg. 2011;49(4):261-9 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/20381221
  6. Onkar PM, Ratnaparkhi C, Mitra K. High-frequency ultrasound in parotid gland disease. Ultrasound Q. 2013;29(4):313-21 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/24263755
  7. Gritzmann. Sonography of the salivary glands. European Radiology. 2003;13(5):964-75 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/12695816
  8. Shimizu M, Okamura K, Kise Y, Takeshita Y, Furuhashi H, Weerawanich W, et al. Effectiveness of imaging modalities for screening IgG4-related dacryoadenitis and sialadenitis (Mikulicz's disease) and for differentiating it from Sjogren's syndrome (SS), with an emphasis on sonography. Arthritis Res Ther. 2015;17:223 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/26298875
  9. Terraz S, Poletti PA, Dulguerov P, Dfouni N, Becker CD, Marchal F, et al. How reliable is sonography in the assessment of sialolithiasis? AJR Am J Roentgenol. 2013;201(1):W104-9 (Level II evidence). https://www.ncbi.nlm.nih.gov/pubmed/23789681
  10. Bag AK, Cure JK, Chapman PR, Singhal A, Haneef Mohamed AW. Imaging of Inflammatory Disorders of Salivary Glands. Neuroimaging Clin N Am. 2018;28(2):255-72 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/29622118
  11. Rzepakowska A, Osuch-Wojcikiewicz E, Sobol M, Cruz R, Sielska-Badurek E, Niemczyk K. The differential diagnosis of parotid gland tumors with high-resolution ultrasound in otolaryngological practice. Eur Arch Otorhinolaryngol. 2017;274(8):3231-40 (Level II evidence). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5500678/
  12. Liu Y, Li J, Tan YR, Xiong P, Zhong LP. Accuracy of diagnosis of salivary gland tumors with the use of ultrasonography, computed tomography, and magnetic resonance imaging: a meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(2):238-45.e2 (Level I evidence). https://www.ncbi.nlm.nih.gov/pubmed/25577417
  13. Wu S, Liu G, Chen R, Guan Y. Role of ultrasound in the assessment of benignity and malignancy of parotid masses. Dentomaxillofac Radiol. 2012;41(2):131-5 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/22116132
  14. Lobo R, Hawk J, Srinivasan A. A Review of Salivary Gland Malignancies: Common Histologic Types, Anatomic Considerations, and Imaging Strategies. Neuroimaging Clin N Am. 2018;28(2):171-82 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/29622112
  15. Brennan PA, Herd MK, Howlett DC, Gibson D, Oeppen RS. Is ultrasound alone sufficient for imaging superficial lobe benign parotid tumours before surgery? Br J Oral Maxillofac Surg. 2012;50(4):333-7 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/21371794
  16. Lee YYP, Wong KT, King AD, Ahuja AT. Imaging of salivary gland tumours. European journal of radiology. 2008;66(3):419-36 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/18337041
  17. Ugga L, Ravanelli M, Pallottino AA, Farina D, Maroldi R. Diagnostic work-up in obstructive and inflammatory salivary gland disorders. Acta Otorhinolaryngol Ital. 2017;37(2):83-93 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/28516970
  18. Abdel Razek AAK, Mukherji SK. State-of-the-Art Imaging of Salivary Gland Tumors. Neuroimaging Clin N Am. 2018;28(2):303-17 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/29622121
  19. Thoeny HC. Imaging of salivary gland tumours. Cancer Imaging. 2007;7:52-62 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/17485257
  20. Terra GT, Oliveira JX, Hernandez A, Lourenco SV, Arita ES, Cortes AR. Diffusion-weighted MRI for differentiation between sialadenitis and pleomorphic adenoma. Dentomaxillofac Radiol. 2017;46(1):20160257 (Level II evidence). https://www.ncbi.nlm.nih.gov/pubmed/27845594
  21. Murdoch-Kinch CA. Salivary gland imaging. J Calif Dent Assoc. 2011;39(9):649-54 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/22034799
  22. Hanna E, Vural E, Prokopakis E, et al. The Sensitivity and Specificity of High-Resolution Imaging in Evaluating Perineural Spread of Adenoid Cystic Carcinoma to the Skull Base. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015;119(2):238-245.e2 (Level I evidence). https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/484751
  23. Weon YC, Park SW, Kim HJ, Jeong HS, Ko YH, Park IS, et al. Salivary duct carcinomas: clinical and CT and MR imaging features in 20 patients. Neuroradiology. 2012;54(6):631-40 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/22307272
  24. Bryan RN, Miller RH, Ferreyro RI, Sessions RB. Computed tomography of the major salivary glands. AJR, American journal of roentgenology. 1982;139(3):547-54 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/6981322
  25. Dong Y, Lei GW, Wang SW, Zheng SW, Ge Y, Wei FC. Diagnostic value of CT perfusion imaging for parotid neoplasms. Dentomaxillofac Radiol. 2014;43(1):20130237 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/24186883
  26. Kikuchi M, Koyasu S, Shinohara S, Imai Y, Hino M, Naito Y. Preoperative Diagnostic Strategy for Parotid Gland Tumors Using Diffusion-Weighted MRI and Technetium-99m Pertechnetate Scintigraphy: A Prospective Study. PLoS One. 2016;11(2):e0148973 (Level II evidence). https://www.ncbi.nlm.nih.gov/pubmed/26849569
  27. Tryggvason G, Gailey MP, Hulstein SL, Karnell LH, Hoffman HT, Funk GF, et al. Accuracy of fine-needle aspiration and imaging in the preoperative workup of salivary gland mass lesions treated surgically. Laryngoscope. 2013;123(1):158-63 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/22991236
  28. Sack, Sack M, Weber R, Weinstein G, Chalian A, Nisenbaum H, et al. Image-Guided Fine-Needle Aspiration of the Head and Neck. Archives of Otolaryngology - Head & Neck Surgery. 1998;124(10):1155-61 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/9776195
  29. Carlson ER. Diagnosis and management of salivary lesions of the neck. Atlas Oral Maxillofac Surg Clin North Am. 2015;23(1):49-61 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/25707565
  30. Gavin-Clavero MA, Uson-Bouthelier T, Jariod-Ferrer UM, Fernandez-Larranaga A, Pantilie B, Lobera-Molina F, et al. Accuracy of FNAC and CT in the differentiation of benign and malignant parotid tumours in a case series. Acta Otorrinolaringol Esp. 2018;69(1):25-9 (Level IV evidence). https://www.ncbi.nlm.nih.gov/pubmed/28844507
  31. Bhatia KSS, Dai YL. Routine and Advanced Ultrasound of Major Salivary Glands. Neuroimaging Clin N Am. 2018;28(2):273-93 (Review article). https://www.ncbi.nlm.nih.gov/pubmed/29622119
  32. Feinstein AJ, Alonso J, Yang SE, St John M. Diagnostic Accuracy of Fine-Needle Aspiration for Parotid and Submandibular Gland Lesions. Otolaryngol Head Neck Surg. 2016;155(3):431-6 (Level IV evidence). https://www.ncbi.nlm.nih.gov/pubmed/27095051
  33. Yerli H, Aydin E, Haberal N, Harman A, Kaskati T, Alibek S. Diagnosing common parotid tumours with magnetic resonance imaging including diffusion-weighted imaging vs fine-needle aspiration cytology: a comparative study. Dentomaxillofac Radiol. 2010;39(6):349-55 (Level II evidence). https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3520240/
  34. Hasson O. Modern sialography for screening of salivary gland obstruction. J Oral Maxillofac Surg. 2010;68(2):276-80 (Level III evidence). https://www.ncbi.nlm.nih.gov/pubmed/20116695
  35. Kassem K, Safia A , Elhadi U. et al. Fine-needle aspiration or core needle biopsy? A meta-analysis of diagnostic accuracy and procedural outcomes in salivary gland tumors Europ J of Radiology 2026; 194:112532

Pathway User Guide

Yellow Boxes Denotes extra information. Some contain single or multiple white sub-boxes, click a white box to reveal detailed information in a pop-up.

White Boxes: Denotes standard pathway steps. (If inside a yellow box, they open a specific pop-up).

Zoom & Pan Controls: Use + / − or the slider to zoom. Reset returns to default. Tick Panning to drag the diagram when zoomed.

Blue “View Full Screen” Button: Opens the whole diagram in a large, full-screen pop-up window. Use Close to exit.

The relative radiation level (RRL) of each imaging investigation is displayed in the pop up box.

SYMBOL RRL EFFECTIVE DOSE RANGE
No radiation None 0
Minimal radiation Minimal < 1 millisieverts
Low radiation Low 1-5 mSv
Medium radiation Medium 5-10 mSv
High radiation High >10 mSv

Disclaimer

Status Of Recommendations Each pathway is designed to assist clinicians in situations when faced with a large array of possible diagnostic tests and examinations. However, it is recognised that diagnostic practice may differ from a particular pathway depending on local availability of equipment and expertise, as well as the experience of individual clinicians. Therefore each pathway is neither a rigid set of rules, nor a substitute for clinical assessment, and individual patient circumstances should always be considered.

Report an Issue

Spotted an error or outdated info? Click to tell us.

SalivaryGlandSwelling Normal Calculi or stenosis Sialadenitis Sialadenosis Solid mass Yes - Suspected massor neoplasm Staging as required No - Salivary swelling,cause unknown Usually no further imaging needed.Investigate and treat underlying cause Clinical history andexamination Are “red flags” present? Ultrasound If further assessment is needed, CT conventional sialography or Imaging guided tissue sampling MRI (or CT) AND MR sialography or

Clinical History and examination

Clinical history and examination are important to determine the most appropriate investigation(s).

There are many causes of salivary gland swelling. Clinical history and examination are important to determine the most appropriate investigation(s).

It is important to recognise “red flag” features in the history and clinical examination

To summarise the benefits of each imaging modality simply for this pathology:

Modality

Benefits

Disadvantages

Ultrasound

Economical

No Radiation

Can evaluate tumour borders/content

Identifies calcified sialoliths

Poorly visualises deep structures

MRI

Very good image resolution and tumour differentiation

Good at assessing ductal anatomy 

Expensive 

Less accessible 

Susceptible to motion artefacts

CT

Accessible 

Identifies calcified sialoliths

Radiation

Poorly differentiates tumours

Can be falsely reassuring

Conventional sialography

Widely available

Excellent resolution of small ducts

Potential for therapeutic intervention

Identifies sialoliths 

Radiation

Invasive

May be technically difficult

Contraindicated in acute infection

Red flag features

It is important to recognise “red flag” features in the history and clinical examination

  • Patient age >60
  • Rapid growth
  • Cutaneous features such as tethering/ulceration
  • Facial nerve palsy
  • Suspected deep lobe of parotid, or minor gland involvement 
  • Cervical lymphadenopathy
  • Past medical history of facial/skin cancer

Ultrasound

US is usually the first line imaging modality in undifferentiated salivary gland swelling

  • Initial imaging modality of choice in undifferentiated salivary gland swelling.
  • Ultrasound can be used to identify:
    • Ductal dilation
    • Calculi (particularly when ≥ 3mm)
    • Abscess formation
    • Alteration of the normal glandular morphology and differentiate salivary gland lumps due to systemic diseases (e.g. Sjögren’s syndrome vs. IgG4 related dacroadenitis and sialadenitis)
    • Mass lesions
  • With correlation with appropriate clinical history, diagnosis of the above can often be made with ultrasound alone.
  • In patients with suspected sialolithiasis and with normal sonographic findings, further assessment with conventional or MR sialography is recommended.
  • For mass lesions in the superficial parotid, submandibular and sublingual glands, ultrasound can be used for initial assessment to determine the margins and internal characteristics, and help differentiate malignant from benign neoplasms (sensitivity 52-73%, specificity 89-94%). That is, US may not confidently differentiate benign and malignant masses, and biopsy will be required. It is recommended that further assessment of neoplasms be performed with cross-sectional imaging (MRI) and/or imaging guided fine needle aspiration cytology.
  • Ultrasound is of limited utility for imaging the deep lobe of the parotid and for the minor salivary glands.
  • If deep tissue extension is suspected or malignancy is confirmed on cytology, either MRI or CT is necessary to evaluate tumour extent, local invasion and perineural spread.

Magnetic Resonance Imaging (MRI)

MRI is the recommended imaging modality to assess solid masses/neoplasms of the salivary glands

  • Imaging modality of choice when there is a strong suspicion of salivary gland malignancy.
  • MRI can differentiate between inflammatory and neoplastic lesions.
  • MRI has better contrast resolution than CT which allows detailed delineation of tumour margins and accurate local staging. Perineural spread, bone invasion and meningeal infiltration can be assessed.
  • For all tumours in the sublingual gland, MRI should be performed as the risk of malignancy is high. As a general rule, the proportion of malignant tumours increases as the salivary gland size decreases (parotid gland 20-30% malignant, submandibular 40-60%, minor salivary glands 50-80%, sublingual glands 70-90%)
  • Sensitivity and specificity for MRI in differentiating malignant vs. benign salivary gland neoplasms are 83-86% and 85-92% respectively.
  • When it comes to perineural spread of tumours, MRI has shown to have a sensitivity of 100% and specificity of 85%.

Computed Tomography (CT)

CT demonstrates abscess formation, calculi, major salivary duct dilatation, acute inflammation, and neoplasms

  • Demonstrates abscess formation, calculi, major salivary duct dilatation and acute inflammation well.
  • Nearly always considered second line to MRI.
  • Potentially falsely reassuring with predominent false negatives, when compared to MRI.
  • In current practice, minor role for identifying major and minor salivary gland tumours and detecting direct extension to adjacent structures (particularly when bony erosion is a concern), neural and lymphatic invasion.
  • Can be used to help to differentiate malignant from benign neoplasms (sensitivity 74-90%, specificity 79-90%), however, the combination of sensitivity and specificity in MRI is higher than for CT.
  • Rapid and cheap compared to MRI but involves exposure to ionising radiation to the head and neck. Useful to assess neoplasms when MRI is contraindicated or where access to MRI is limited.

Imaging-guided Fine Needle Aspiration Cytology (FNAC)

Image -guided sampling allows accurate differentiation between benign and malignant tumours of salivary glands

  • Widely used for diagnosis of salivary gland tumours and can predict if the lesion is benign or malignant with an accuracy of 81-98%.
  • Although the combined sensitivity (80-82%) and specificity (95-97%) of FNAC in differentiating malignant from benign tumours is high, there is a relatively high non-diagnostic rate of about 10% due to sampling errors. It is currently recommended that neoplasms be characterised with cross-sectional imaging in conjunction with FNAC for pre-surgical decision making.

Core needle biopsy (CNB)

Recent evidence from a meta-analysis reported that CNB provides much higher sensitivity than FNAC, similar high specificity, fewer non-diagnostic procedures (with less need for repeats) but a slightly increased (but rare) risk of haematoma .

Conventional Sialography

Conventional (radiographic) sialography provides detailed imaging of the salivary ductal system

  • An invasive technique in which iodinated contrast is directly injected into the main ducts of the parotid or submandibular glands with radiographs obtained to allow detailed assessment of ductal strictures or presence of calculi.
  • Can be combined with therapeutic salivary interventional procedures which focus on gland preservation (e.g. stone retrieval, balloon ductoplasty of strictures) in some centres.
  • There are  risks of complications such as damage to the orifice, overfilling and rupture of the ductal system, exacerbation of infection, and adverse reactions to contrast material.
  • Conventional sialography is generally superior to MR sialography in demonstrating very small calculi and detailing the smallest ductal branches
  • MR sialography is superior to conventional sialography in demonstrating parenchymal changes
  • Conventional sialography is contraindicated when there is acute salivary gland infection

Computed Tomography (CT)

CT can identify small calculi, especially in the submandibular gland where the vast majority are radio-opaque. CT can also assess gland atrophy, variant anatomy and help surgical planning

Magnetic Resonance Sialography

MR sialography is a non-invasive alternative to conventional sialography

  • Non-invasive method to characterise the ductal structure and identify calculi and stenosis of the parotid and submandibular glands.
  • Several studies have demonstrated that MR sialography is generally as accurate as conventional sialography in detecting obstructions, stenosis and stricture of the main ducts.
  • MR sialography is superior to conventional sialography in demonstrating parenchymal changes
  • For the small percentage of radiolucent calculi, MR sialography has a role

  • Acute Abdomen
  • Breast
  • Cancer Staging
  • Cardiovascular
  • Ear, Nose & Throat
  • Endocrine
  • Gastrointestinal
  • Kidney and Urinary Tract
  • Liver and Biliary
  • Musculoskeletal Non-Trauma
  • Neurological
  • Obstetric & Gynaecological
  • Paediatric
  • Pancreas
  • Respiratory
  • Trauma
    • Trauma - Musculoskeletal
    • Trauma - Head
    • Trauma - Visceral
    • Trauma - Paediatric
  • Ear Nose & Throat

    • Ear, Nose & Throat
      • Laryngeal Cancer (Staging)
      • Salivary Gland Swelling
      • Sinusitis (acute)
      • Sinusitis (Chronic, Suspected)
      • Tinnitus
      • Vertigo (Recent Onset)

    Diagnostic Imaging Pathways

    The DIP pathways are a step-by-step guides to help clinicians choose the most appropriate imaging for each clinical scenario 

    “Trusted by clinicians worldwide since 2007, Diagnostic Imaging Pathways provides clear, evidence-based imaging guidelines. Our pathways support better decision-making and help improve healthcare outcomes—especially in emerging nations. 

    DIP functions and thrives wholeheartedly under the pillars of diversity, inclusivity and respect for all."

    • Pathways
    • Normal Anatomy
    • Medical Images
    • Radiation Module
    • Radiation Quiz
    • Information for Consumers
    • Governance
    • About Imaging
    • Production
    • Search
    • Login
    • Get in Touch
    © Diagnostic Imaging Pathways (DIP) 2025
    Code of Conduct    Terms and Conditions of Use
    General Site Navigation

    Information For Consumers

    • General Information About Diagnostic Imaging
      • Colorectal (Bowel) Cancer Screening
      • Colorectal (Bowel) Cancer Screening (Australia)
      • Consent to Procedure or Treatment
      • Radiation Risks of X-rays and Scans
    • Imaging Pathways
      • Ankle Injury (Suspected)
      • Bowel Cancer (Staging)
      • Deep Venous Thrombosis ( Leg, Suspected)
      • Deep Venous Thrombosis (Arm, Suspected)
      • Headache (Constant or Repeated)
      • Hip Fracture (Suspected)
      • Hypertension
      • Low Back Pain (Acute)
      • Lung Cancer (Staging)
      • Neck Pain (Non-Traumatic)
      • Renal Colic
      • Respiratory Illness (Acute)
      • Scaphoid Fracture (Suspected)
      • Shoulder (Pain or Instability)
      • Sinusitis (Acute)
      • Sinusitis (Chronic)
      • Stress Fracture (Suspected)
    • Imaging Procedures
      • Angiography (Angiogram)
      • Arthrogram
      • Bone Scan
      • Computed Tomography (CT)
      • Computed Tomography (CT) Angiography
      • Inferior Vena Cava (IVC) Filters
      • Intravenous Pyelogram (IVP)
      • Magnetic Resonance Angiography (MRA)
      • Magnetic Resonance Imaging (MRI)
      • Myelogram
      • Orthopantomogram (OPG)
      • Percutaneous Transthoracic Fine Needle Aspiration (FNA) or Biopsy
      • Positron Emission Tomography (PET)
      • Renal Artery Angioplasty and Stent
      • Renal Scan
      • Ultrasound
      • Ultrasound (Doppler)
      • Ultrasound (Endoscopic Rectal)
      • Venography (Venogram)
      • X-ray (Chest)
      • X-ray (Plain Radiograph)

    Governance

    • History
      • 1990s to 2012
      • 2012 to 2016
      • 2016 to 11 April 2022
      • From 12 April 2022
      • Introduction
      • List of acronyms used on this site
    • Organisation
      • 2003 - 2012
      • 2013 - 2016
      • 2017 - 11 April 2022
      • Post 12 April 2022
    • Personnel
      • Clinical Advisors
      • Contractors
      • Contributors
      • Editor
      • Editorial Panel - Post 2022
      • Editorial Panel - Pre 2022
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Project Officers
      • Quality Coordinator
      • Research Registrar
      • Responsibilites
      • Steering Committee
      • Steering Committee
    • Responsibilities, Achievements
      • Accreditation and Endorsement
      • Clinical Advisors
      • Editor
      • Editorial Panel
      • Executive Sponsor
      • Information Technologist
      • Manager
      • Other Personnel
      • Pathway Creation, Review and Revision
      • Quality Coordinator
      • Research Registrar
      • Steering Committee

    About Imaging

    • About Imaging
      • Bleeding Risk and Assessment
      • General Principles in Requesting and Providing Imaging Investigations
      • Imaging During Pregnancy and Lactation
      • Ionising Radiation in Diagnostic Imaging
      • Ionising Radiation in Paediatric Imaging
    • Common Procedures
      • Computed Tomography
      • Gastrointestinal Contrast Examinations
      • High Resolution Computed Tomography
      • Magnetic Resonance Imaging
      • Nuclear Medicine
      • Positron Emission Tomography
      • Ultrasound
    • Contrast Agents
      • Gadolinium Contrast for MRI scans
      • Iodinated Contrast for CT scans
      • Ultrasound Contrast Media

    Production

    • Editorial Independence
      • Disclosure of Conflict of Interest
      • Funding Policy & Sources
      • Management of Conflict of Interest
    • Processes for Creating and Managing Content
      • Creation of a New Pathway
      • Creation of New Information for Consumers
      • Review and Revision of a Pathway
      • Review and Revision of Information for Consumers
    • Production
      • Initial Engagement with Consumers
      • Principles for Creating and Managing Content